NEWCaplight raises a $16M Series A, led by BlackRock and Fin Capital →
Skip to main content
Caplight Logo









Polares Medical

Polares Medical

Private
LausanneHealthcare & Life Scienceshttps://www.polaresmedical.com/

Last Round

Series C

Mar 3, 2026

Total Funding Raised

$115M

Momentum

Top 25%

of companies Caplight tracks

Company Overview

Polares Medical is a medical device company developing a trans-catheter mitral valve hemi-replacement system to treat patients suffering from mitral regurgitation.

Sector

Healthcare & Life Sciences

Verticals

Medical Devices, Clinical Trials

Business Model

B2B

Customer Profile

Hardware Sales

AI Layer

Non-AI

Keywords

structural heart devicetranscatheter mitral valve repairmitral regurgitationminimally invasive surgerystructural heartmitral valve therapyTMVRinterventional cardiologycardiac devicemedical implantheart valve replacementmedtechclinical-stage biotech

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Polares Medical Comparables

Compare Polares Medical with similar companies based on industry and business-model similarity.

Polares Medical comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
NeoChord
91%
4C Medical Technologies, Inc.
90%
HighLife Medical
90%

Polares Medical Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Series CMar 3, 2026
Series BJun 25, 2020
Series AJul 17, 2018

Key People

Founding team and executive leadership

Alex Khairkhahan

Inventor, Founder, Chief Operating Officer, General Manager

Founding Team

Polares Medical Investors

Notable investors and investment history

Polares Medical investors
InvestorRounds
Longitude CapitalSeries B
Endeavour VisionSeries A, Series B
IDO InvestmentsSeries A, Series B
DC Global VenturesSeries C
Earlybird Venture CapitalSeries A, Series B
Wellington PartnersSeries A, Series B
Decheng CapitalSeries B, Series A, Series C

Market signals

Structured signals derived from secondary market and firmographic data.

  • Mar 4, 2026

    Developing MRace Posterior Leaflet Replacement (PLR) system for mitral regurgitation.

  • Mar 3, 2026

    $50M Series C round completed.

Polares Medical Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Polares Medical Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Polares Medical's valuation, stock price, and market status.

Firmographic Details

HeadquartersLausanne
Employee Range21
Year Founded2010
Last FundingMar 3, 2026

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.